All data are based on the daily closing price as of February 7, 2025
d

Daewoong

003090.KO
14.62 USD
-0.35
-2.34%

Overview

Last close
14.62 usd
Market cap
597.90M usd
52 week high
20.31 usd
52 week low
9.90 usd
Target price
19.26 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.4726
Price/Book Value
0.839
Enterprise Value
845.82M usd
EV/Revenue
0.6539
EV/EBITDA
5.1879

Key financials

Revenue TTM
1.26B usd
Gross Profit TTM
647.67M usd
EBITDA TTM
173.15M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
2.01B usd
Net debt
N/A usd

About

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.
  • Symbol
    003090.KO
  • Exchange
    KO
  • Isin
    KR7003090008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Yeong-Hwan Yoon
  • Headquarter
    Seongnam
  • Web site
    https://www.daewoongholdings.com

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top